FDA Links COVID Vaccines to Deaths of 10 Children, Policy Changes Announced

The U.S. Food and Drug Administration (FDA) has identified a possible link between COVID-19 vaccinations and the deaths of 10 children, prompting significant changes in vaccination policy. This revelation comes from an internal memo authored by Vinay Prasad, the FDA’s chief medical and scientific officer, who stated that these fatalities are related to the vaccines. The findings, based on an initial review of 96 deaths reported between 2021 and 2024, have not yet undergone peer review, raising questions about their implications for public health.

In response to this information, Health Secretary Robert F. Kennedy Jr. has announced new guidelines restricting access to COVID-19 vaccines, now limited to individuals aged 65 and older, as well as those with specific underlying health conditions. This marks a stark departure from previous government endorsements of the vaccines as critical tools in combatting the pandemic. During the administrations of both Donald Trump and Joe Biden, U.S. health officials consistently promoted these vaccinations as lifesaving measures.

Prasad’s memo, which was shared with FDA staff, indicates that “no fewer than 10” of the deaths are associated with COVID-19 vaccinations. He expressed concern over the implications of the findings, noting, “It is difficult to read cases where kids aged 7 to 16 may be dead as a result of COVID vaccines.” The memo did not specify details regarding the health conditions of the deceased children or the vaccine manufacturers involved.

The FDA’s analysis has drawn scrutiny from experts in the field. Dorit Reiss, a professor of law at UC Law San Francisco, criticized Prasad’s conclusions, highlighting that they stem from an unpublished investigation. She noted that Prasad’s expertise does not lie in vaccines, a fact that complicates the credibility of his recommendations for changing vaccine approval processes.

According to data from the Centers for Disease Control and Prevention (CDC), there were 1,071 COVID-19-related deaths among individuals aged 5 to 18 from January 4, 2020, to June 24, 2023. While vaccine experts generally advocate for COVID-19 vaccinations based on their efficacy, Prasad’s memo argues that the risks may not be outweighed by the benefits. He cautions against comparing the risks of vaccine-related deaths with those caused by COVID-19, asserting, “We do not know how many fewer kids would have died had they been vaccinated.”

In a television interview, FDA Commissioner Marty Makary affirmed the effectiveness of COVID-19 vaccines for older populations, stating, “The COVID shot was amazing for people at risk and for older people, especially when it was a good match for the circulating virus.” Recent studies have indicated that updated versions of the vaccine have successfully prevented severe outcomes, such as hospitalizations and death, particularly among U.S. veterans.

This emerging situation highlights the ongoing debates surrounding vaccine safety and efficacy, particularly among young populations. As the FDA prepares to implement stricter requirements for vaccine studies, public health experts are left examining the agency’s assertions and their broader implications for vaccination strategies moving forward.